Literature DB >> 11377858

Glial cell line-derived neurotrophic factor promotes survival and induces differentiation through the phosphatidylinositol 3-kinase and mitogen-activated protein kinase pathway respectively in PC12 cells.

Z Chen1, Y Chai, L Cao, A Huang, R Cui, C Lu, C He.   

Abstract

PC12-GFRalpha1 cells, a clonal cell line engineered to express glial cell line-derived neurotrophic factor receptor alpha1 were constructed. Given glial cell line-derived neurotrophic factor could induce the differentiation and promote the survival of PC12-GFRalpha1 cells at low concentrations, the cells provide an unlimited source of monoclonal cells for studies on the signal transduction pathway of glial cell line-derived neurotrophic factor. To characterize the involvement of the mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways in the biological effect of glial cell line-derived neurotrophic factor, we used the mitogen-activated protein kinase kinase inhibitor PD98059 and the phosphatidylinositol 3-kinase inhibitor LY294002. PD98059 blocked glial cell line-derived neurotrophic factor-induced PC12-GFRalpha1 cells neurite formation in a dose-dependent manner, without significantly altering cell viability. LY294002 reversed the survival-promoting effect of glial cell line-derived neurotrophic factor on the PC12-GFRalpha1 cells in serum-deprived medium. The present study demonstrates that phosphatidylinositol 3-kinase pathway seems to mediate the survival-promoting effect of glial cell line-derived neurotrophic factor on PC12-GFRalpha1 cells, while the activation of mitogen-activated protein kinase pathway could be an important step in mediating PC12-GFRalpha1 cells differentiation induced by glial cell line-derived neurotrophic factor. Therefore, it is inferred that similar intracellular signaling components are used by distinct growth factors toward a common biological effect.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11377858     DOI: 10.1016/s0306-4522(01)00093-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  7 in total

1.  Substrate specificity of R3 receptor-like protein-tyrosine phosphatase subfamily toward receptor protein-tyrosine kinases.

Authors:  Juichi Sakuraba; Takafumi Shintani; Sachiko Tani; Masaharu Noda
Journal:  J Biol Chem       Date:  2013-06-28       Impact factor: 5.157

2.  Ethanol impairs activation of retinoic acid receptors in cerebellar granule cells in a rodent model of fetal alcohol spectrum disorders.

Authors:  Ambrish Kumar; Chandra K Singh; Donald D DiPette; Ugra S Singh
Journal:  Alcohol Clin Exp Res       Date:  2010-03-01       Impact factor: 3.455

3.  Glial cell line-derived neurotrophic factor receptor-α1 expressed in striatum in trans regulates development and injury response of dopamine neurons of the substantia nigra.

Authors:  Nikolai Kholodilov; Sang Ryong Kim; Olga Yarygina; Tatyana Kareva; Jin Whan Cho; Amy Baohan; Robert E Burke
Journal:  J Neurochem       Date:  2011-01-19       Impact factor: 5.372

4.  Age and α-synuclein expression interact to reveal a dependence of dopaminergic axons on endogenous Akt/PKB signaling.

Authors:  Sang Ryong Kim; Vincent Ries; Hsiao-Chun Cheng; Tatyana Kareva; Tinmarla F Oo; W Haung Yu; Karen Duff; Nikolai Kholodilov; Robert E Burke
Journal:  Neurobiol Dis       Date:  2011-07-18       Impact factor: 5.996

5.  Intracellular signalling pathways in dopamine cell death and axonal degeneration.

Authors:  Robert E Burke
Journal:  Prog Brain Res       Date:  2010       Impact factor: 2.453

Review 6.  Glial Cell Line-Derived Neurotrophic Factor and Focal Ischemic Stroke.

Authors:  Zhe Zhang; Grace Y Sun; Shinghua Ding
Journal:  Neurochem Res       Date:  2021-02-16       Impact factor: 4.414

Review 7.  Cytokine-, Neurotrophin-, and Motor Rehabilitation-Induced Plasticity in Parkinson's Disease.

Authors:  Gabriella Policastro; Matteo Brunelli; Michele Tinazzi; Cristiano Chiamulera; Dwaine F Emerich; Giovanna Paolone
Journal:  Neural Plast       Date:  2020-11-26       Impact factor: 3.599

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.